098 - MedTech vs. Aerospace Risk Management, AFAP vs. ALARP/ALARA, Quantifying Benefit, Risk Control Measures, and Risk Management Reports with Bijan Elahi

Let's Combinate · 16 Aug 2023 · 40m

What this episode covers

Bijan Elahi, a Technical Fellow and Medtronic corporate Advisor on safety risk management, explains the fundamental differences between MedTech and Aerospace risk management, noting that MedTech balances risk against benefit while Aerospace focuses on elimination. He details the challenges of quantifying risk using ISO 14971, advocating for quantitative methods over qualitative guesswork to provide objective evidence of safety. Elahi also discusses the regulatory requirements of the EU MDR, specifically the 'as far as possible' (AFAP) standard, and how companies determine when risk reduction is sufficient without adversely affecting the benefit-risk ratio.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 40m

    Inside Look into ISO 14971:2019 & ISO TR 24971:2020 from the Author's Point of View

    Ed Bills, a risk management consultant and technical committee member for ISO 14971:2019 and ISO TR 24971:2020, joins host Jon Speer to explain the nuances of the updated international medical device risk management standards. They discuss the separation of guidance from requirements, the critical role of post-market surveillance in Clause 10, and the regulatory landscape involving the EU MDR and IVDR. Bills emphasizes that risk management is a product safety standard distinct from business or project risk, and advises companies to read the full rationale and technical report to avoid common misinterpretations.

  • Global Medical Device Podcast · 1h 03m

    #422: ISO 14971 and the Road to Risk Management with Edwin Bills

    Edwin Bills, a lead expert in medical device risk management and key contributor to ISO 14971, explains how his background as a submariner and manufacturing quality engineer informs his approach to patient safety and cost of quality. He details the critical link between manufacturing process capability (CPK), supplier quality, and financial risk, arguing that quality failures directly impact a company's bottom line and reputation. Bills critiques common industry practices, such as late-stage FMEA and manual spreadsheet-based traceability, advocating for early hazard analysis, industrial statistics, and integrated software solutions to manage complex risks in medical devices and combination products.

  • Global Medical Device Podcast · 36m

    #325 The Role of dFMEAs in Risk Management for Medical Devices

    Wade Schroeder, a medical device expert at Greenlight Guru, explains how dFMEA and ISO 14971 work together to manage risk in medical device design. He argues that while dFMEA provides a useful bottom-up technical view, ISO 14971 offers a necessary top-down, patient-focused strategy that maps directly to FDA expectations. Schroeder highlights Greenlight Guru’s software as a tool that integrates risk management with design controls, reducing the complexity of maintaining separate systems. The discussion emphasizes using tools like fault tree analysis and fishbone diagrams to ensure comprehensive safety without compromising regulatory compliance.

  • Global Medical Device Podcast · 39m

    #362: Managing Risk in Clinical Investigations

    Helene Quie, a medical device regulatory expert, explains the dual nature of risk management in clinical investigations, distinguishing between residual product safety risks and procedural risks inherent in study protocols. She emphasizes the need for measurable, data-driven benefit-risk assessments to satisfy ethics committees and competent authorities, particularly under the EU MDR. Quie highlights the operational challenges of enrolling vulnerable patient populations, such as children or acute patients, and the regulatory confusion surrounding the integration of AI in medical devices.

  • Global Medical Device Podcast · 33m

    How AI Can Help You Manage Risk

    Tyler Foxworthy, Chief Scientist at Greenlight Guru, explains how his company applies Bayesian statistics and machine learning to transform medical device risk management from qualitative guesswork into rigorous, probabilistic assessment. He details how the platform mines FDA data and clinical literature to update risk probabilities, addressing the industry's struggle with false precision and the limitations of human intuition regarding rare events. Foxworthy argues that adopting these models, pioneered in nuclear and aerospace sectors, allows companies to right-size clinical sample sizes, reduce uncertainty, and accelerate time to market by providing statistically defensible confidence intervals.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.